BioSpace News Archive

Genetown

Synlogic to Present Data at the American Association for Cancer Research 2018 Annual Meeting

Synlogic Inc. announced that preclinical data from its immuno-oncology (IO) program will be presented at the upcoming annual meeting of the American Association for Cancer Research (AACR) being held April 14 to 16, 2018, in Chicago.

March 19, 2018
·
1 min read
Policy

Trump Misses Target on Opioids: Down With Wall, Up With Port Security, Say Ex-WH Drug Spokesman Robert Weiner and Analyst Ben Lasky--Oped in Youngstown OH Vindicator

Robert Weiner, the White House Drug Policy Spokesman under Presidents Bill Clinton and George Bush, said that President Trump’s insistence on a wall again today, during his opioids announcement in New Hampshire, “misses the target on opioids and other drugs.”

March 19, 2018
·
2 min read
Pharm Country

The National Center on Addiction and Substance Abuse’s Response to President Trump’s Initiative to Tackle the Opioid Crisis

We thank President Trump for addressing our nation’s opioid crisis by releasing his “Initiative to Stop Opioid Abuse and Reduce Drug Supply and Demand.”

March 19, 2018
·
2 min read
Business

GBT Reports Fourth Quarter 2017 Results

Biotoscana Investments S.A. announced its results for the 4Q17 and full year of 2017.

March 19, 2018
·
1 min read
Policy

MYRIAD GENETICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Myriad Genetics, Inc. To Contact The Firm

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Myriad Genetics, Inc.

March 19, 2018
·
1 min read
Pharm Country

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Sanofi, Shire, TherapeuticsMD, and Zogenix

WallStEquities.com are offering reports on SNY, SHPG, TXMD, and ZGNX.

March 19, 2018
·
4 min read
Business

Knight Announces Exclusive License Agreement with Ardelyx for Tenapanor

Knight Therapeutics announced a license agreement with Ardelyx Inc. that provides Knight with exclusive rights to commercialize tenapanor in Canada.

March 19, 2018
·
4 min read
Medicure Announces an Up-Date on PREXXARTAN Launch

Medicure had intended to launch PREXXARTAN® during the first half of 2018.

March 19, 2018
·
4 min read
Business

DarioHealth Reports Fourth Quarter and Year End 2017 Results

Record 4Q 2017 Revenue of $1.6 Million; growth of 88% Record 2017 Revenue of $5.2 Million; growth of 84%

March 19, 2018
·
17 min read
FDA

FDA grants Fast Track designation to nintedanib for the treatment of systemic sclerosis with associated interstitial lung disease

Fast Track designation facilitates development of new therapies that treat serious conditions and fulfill an unmet medical need.

March 19, 2018
·
6 min read